Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Octreotide acetate Pen bulk supplier for pharma manufacturers

Octreotide Acetate Pen 2,500 mcg/mL prefilled pen Suppliers & Bulk Manufacturers

Available Forms: injection (prefilled syringe)

Available Strengths: 2,500 mcg/mL prefilled pen

Reference Brands: -

Category: Oncology Cancer Care

Octreotide acetate 2,500 mcg/mL prefilled multi-dose pen for subcutaneous self-injection in acromegaly and neuroendocrine tumour symptoms. For hospital, oncology and specialty importers with a 2-8 °C chain.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Octreotide Acetate Pen? List it or send an offer →

Product Description:

Octreotide is a synthetic peptide analogue of somatostatin, the hormone that switches off the release of many others. It binds mainly somatostatin receptor subtypes 2 and 5 and suppresses growth hormone, insulin, glucagon, gastrin, serotonin and vasoactive intestinal peptide. This page covers octreotide acetate 2,500 mcg/mL in a prefilled multi-dose pen for subcutaneous injection. Short-acting octreotide is given two or three times a day, and the pen lets patients dial a dose at home instead of drawing it from ampoules.

Approved uses follow those of short-acting octreotide: acromegaly where surgery or radiotherapy has not controlled growth hormone, the severe diarrhoea and flushing of metastatic carcinoid tumours, and the watery diarrhoea of VIP-secreting tumours. Injection sites are rotated. Gallstones can form with long use, so periodic ultrasound is advised. Blood glucose may rise or fall, and antidiabetic doses may need adjusting. Thyroid function, heart rate and vitamin B12 are monitored. Octreotide reduces the absorption of ciclosporin and can slow that of other oral drugs.

Sourcing notes. Octreotide is prescription-only and usually moves through specialist hospital or oncology channels. Unopened pens need a 2-8 °C cold chain and protection from light; in-use storage after first injection follows the approved label. As a drug-device combination, the CTD dossier should cover pen mechanism, dose accuracy and cartridge as well as peptide-related impurities. Confirm whether pen needles are in the pack. Request a CoA per batch, GMP certificate, CoPP and temperature logger data for each shipment. State pens per pack, needle needs and label language.

Octreotide Acetate Pen — third party manufacturing & bulk supply

Octreotide Acetate Pen 2,500 mcg/mL prefilled pen is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Octreotide Acetate Pen is supplied as injection (prefilled syringe) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Octreotide Acetate Pen listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Octreotide Acetate Pen →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

A prefilled, multi-dose pen of octreotide acetate for subcutaneous injection. The best-known example is Bynfezia Pen, approved in the US in 2020.

Bynfezia Pen is approved in the US. Tell us your market and we will check which octreotide pens and injections are registered there and how they can be supplied.

The same uses as octreotide injection in vials: acromegaly, and the severe diarrhoea and flushing caused by carcinoid tumours and VIP-secreting tumours.

See our main octreotide injection page for vials, depot formulations and octreotide API, or send us an RFQ with the product and market.

Related Products

Doxorubicin Liposomal

Strength:
20 mg/10 mL (2 mg/mL), 50 mg/25 mL (2 mg/mL)

Form: Liposomal Injection (

Reference Brands: Doxil® , Caelyx® (EU & US)

View Details
Vinblastine Sulfate

Strength:
10 mg/10 mL (1 mg/mL), 10 mg/1 mL

Form: Injection

Reference Brands: Velban® (EU & US)

View Details
Topotecan Capsule

Strength:
Capsule: 1 mg, 2.5 mgL

Form: Oral capsules

Reference Brands: Hycamtin® (EU & US)

View Details
Carbamazepine

Strength:
100 mg, 200 mg, 400 mg; Suspension: 100 mg/5 mL

Form: Oral Tablets and Suspension

Reference Brands: Tegretol®, Tegretol XR® (US & EU)

View Details
Thalidomide

Strength:
50 mg, 100 mg, 150 mg , 200 mg

Form: Capsules

Reference Brands: Thalomid® (US)

View Details
5 Flucel 250mg Injection

Strength:
50 mg/mL (2.5 g/50 mL and 5 g/100 mL vials)

Form: Injection

Reference Brands: Adrucil (US)

View Details
Vincristine Sulphate Injection

Strength:
1 mg/10 mL (0.1 mg/mL), 2 mg/10 mL (0.2 mg/mL)

Form: Injection

Reference Brands: Oncovin®(US)

View Details
Teniposide Injection

Strength:
50 mg/5 mL (10 mg/mL) ampoule

Form: Injection

Reference Brands: Vumon (US/EU)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us